-
Recent Posts
Archives
- March 2023
- November 2021
- December 2020
- November 2020
- March 2020
- December 2019
- November 2019
- September 2019
- July 2019
- February 2019
- September 2017
- November 2016
- September 2016
- June 2016
- May 2016
- March 2016
- October 2015
- August 2015
- May 2015
- July 2014
- June 2014
- April 2013
- March 2013
- February 2013
- January 2013
Categories
Meta
Monthly Archives: January 2013
Journal Club review: Risk Factors in Critical Illness Myopathy during the early course of Critical Illness – a Prospective Observational Study
Summary for General Readers As discussed in the accompanying primer, I chose to review a research article (Weber-Carstens et al., 2010) I found that looked both at risk factors for development of critical illness myopathy and a new diagnostic test for … Continue reading
Primer on Critical Illness Myopathy for General Readers
Neurology in Critical Care Despite the fact that Critical Care and Neurology are separately relatively “glamorous” medical disciplines, neurological diseases in the critical illness setting receive relatively little attention. However, if one is in the business of intervening to make … Continue reading
Journal Club Review: A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson’s Disease
Summary for General Readers Given it was first introduced to treat Parkinson’s disease in the 1960’s (see the accompanying background information on Parkinson’s disease for general readers), it is surprising that it was not until four decades later that a major … Continue reading
Posted in Parkinson's Disease
Tagged L-DOPA, Neuroprotection, Parkinson Disease, Rasagiline
Leave a comment
Primer on Parkinson’s Disease for General Readers
Pathology Parkinson’s Disease (PD) is a relatively common condition affecting around 1% of all individuals aged over 60, and increasing towards 5% of those over 80. It is characterised by neurodegeneration, a “wearing out” of certain groups of nerve cells … Continue reading